- Home
- MBOT vs ACOG Comparison
MBOT vs ACOG Comparison
Compare MBOT & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBOT
- ACOG
- Stock Information
- Founded
- MBOT 2010
- ACOG 2000
- Country
- MBOT United States
- ACOG Canada
- Employees
- MBOT N/A
- ACOG N/A
- Industry
- MBOT Medical/Dental Instruments
- ACOG
- Sector
- MBOT Health Care
- ACOG
- Exchange
- MBOT Nasdaq
- ACOG Nasdaq
- Market Cap
- MBOT 94.6M
- ACOG 80.3M
- IPO Year
- MBOT N/A
- ACOG N/A
- Fundamental
- Price
- MBOT $2.60
- ACOG $10.80
- Analyst Decision
- MBOT Strong Buy
- ACOG Strong Buy
- Analyst Count
- MBOT 1
- ACOG 1
- Target Price
- MBOT $9.00
- ACOG $20.00
- AVG Volume (30 Days)
- MBOT 1.0M
- ACOG 67.4K
- Earning Date
- MBOT 08-13-2025
- ACOG 08-14-2025
- Dividend Yield
- MBOT N/A
- ACOG N/A
- EPS Growth
- MBOT N/A
- ACOG N/A
- EPS
- MBOT N/A
- ACOG N/A
- Revenue
- MBOT N/A
- ACOG $2,928,654.00
- Revenue This Year
- MBOT N/A
- ACOG N/A
- Revenue Next Year
- MBOT N/A
- ACOG N/A
- P/E Ratio
- MBOT N/A
- ACOG N/A
- Revenue Growth
- MBOT N/A
- ACOG N/A
- 52 Week Low
- MBOT $0.82
- ACOG $3.75
- 52 Week High
- MBOT $3.38
- ACOG $11.54
- Technical
- Relative Strength Index (RSI)
- MBOT 54.60
- ACOG N/A
- Support Level
- MBOT $2.44
- ACOG N/A
- Resistance Level
- MBOT $2.77
- ACOG N/A
- Average True Range (ATR)
- MBOT 0.13
- ACOG 0.00
- MACD
- MBOT 0.01
- ACOG 0.00
- Stochastic Oscillator
- MBOT 63.83
- ACOG 0.00
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.